The AMR-ARRAY, a 55-plex Luminex® MagPlex-TAG Bead Array for Detection of Genetic Determinants of Resistance to Beta-Lactams, (Fluoro) Quinolones and Colistin, Aminoglycosides and Macroslides

Speaker
  • Scientist, Sciensano
    Biography
      Cécile Boland graduated in 2007 from the UCL as a Bio-engineer. After three years of research work in a biotech company and in the Scientific Institute of Public Health, she performed a PhD in collaboration with the Veterinary and Agrochemical Research Centre (CODA-CERVA) and the Laboratory of Food and Environmental Microbiology (UCL) and held a PhD in 2014 from the Bio-engineer faculty of the UCL. Since then, she worked as a scientist at CODA-CERVA and is currently scientist in veterinary bacteriology at Sciensano.

    Abstract

    Purpose:
    Molecular characterization of antimicrobial resistance determinants is recommended to monitor the mechanisms underlying antimicrobial resistance in indicator bacteria such as Escherichia coli. An affordable all-in-one alternative to whole genome sequencing is welcome to conduct the monitoring of critical antimicrobial resistance determinants in large collections of indicator or pathogenic bacteria in a one-health context

    Methods:
    Here we present a rapid genetic screening system based on a home-made multiplex Ligase Chain Reaction (LCR) assay using padlock probes coupled with a MagPlex-TAG beads hybridization and analysis on a Luminex® 200 TM platform. This 55-plex array, called the AMR-ARRAY, has been developed to detect the main antibiotic resistance determinants against β-lactams, (fluoro)quinolones, colistin, aminoglycosides and macrolides in E. coli, Shigella and Salmonella spp and can be used for other Enterobacteriaceae.

    Results:
    The mix of 55 probes was validated with available reference strains carrying the corresponding resistance gene or mutation. The array performed successfully on both reference and field strains. Four hundred eighty-one strains resistant to β-lactams, (fluoro)quinolones and/or colistin isolated in Belgium from food-producing animals (179 E. coli), food chain (117 E. coli), human samples (66 Salmonella spp. and 100 Shigella spp.) and 19 EURL-AR reference strains (9 E. coli and 10 Salmonella spp.) were assayed with a reduced version of this array (41-plex targeting β-lactams, (fluoro)quinolones and colistin resistance markers). Results were compared with phenotypic resistance profiles determined for the animal strains and with sequence-inferred resistance profiles determined for the other strains (using Sanger sequencing or PCR as reference method). The array performed well in detecting critical genetic determinants underlying antimicrobial resistance since 97.8% (175/179) of the food-producing animal strains yielded bead array profiles fully compatible with phenotypic resistance. For the genotype comparison, the array has a good performance too. The bead array profiles matched Sanger or PCR genotypes for 95.7% (112/117) of the food chain isolates, 97.6% (162/166) of the human isolates and 94.7% (18/19) of the inter-laboratory tests strains, giving a global genotypic concordance of 96.7% (292/302).

    Conclusion:
    We have developed in-house a 55-plex LCR/Luminex® MagPlex-TAG bead array able to detect the main antibiotic resistance determinants against β-lactams, (fluoro)quinolones, colistin, aminoglycosides and macrolides in Gram-negative bacteria. The performance of a reduced version of this array (41-plex targeting β-lactams, (fluoro)quinolones and colistin resistance markers) was evaluated with a collection of 481 field strains and a global concordance of 97.1% (467/481) was observed between the bead-array results and results obtained either by susceptibility testing or by genotyping using Sanger sequencing or PCR. The evaluation of the performance of the 55-plex AMR-ARRAY with field strains resistant to aminoglycosides and macrolides is ongoing.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    MAY 12, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 12, 2020 9:00 AM PDT
    NEW DATE: Date: May 12, 2020 Time: 9:00am PDT, 12:00pm EDT...
    JUN 30, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 30, 2020 9:00 AM PDT
    DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
    Loading Comments...
    Show Resources